Skip to main content
OpenTrials
Completed

NCT Number: NCT00743132

Novel Prediction Score for Postoperative Acute Renal Failure (ARF) Following Liver Resection

ARF is a frequent event after hepatic resection and therefore clinically highly relevant.

There is limited evidence on the incidence of postoperative ARF and its clinical relevance in patients undergoing liver resection.

This study will evaluate the incidence of acute renal failure (ARF) after liver resection and its impact on postoperative mortality.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Swiss HPB (Hepato-Pancreato-Biliary) Center of the University Hospital Zurich

Zurich, Canton of Zurich, 8091, Switzerland

About this study

ARF is a frequent event after hepatic resection and therefore clinically highly relevant.

There is limited evidence on the incidence of postoperative ARF and its clinical relevance in patients undergoing liver resection.

This study will evaluate the incidence of acute renal failure (ARF) after liver resection and its impact on postoperative mortality.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient age >/= 18 years
  • Benign and malign liver diseases

Exclusion criteria

  • Trauma cases

Treatment and study plan

Primary outcomes

  1. Predictor score

  2. Incidence of ARF Length of hospital stay

Sponsors and collaborators

Lead sponsor

University of Zurich

Other

Registry information

Acronym: StV 11-2008

Important dates

Study start
2008
Primary completion
2008
Study completion
2008
First posted
Aug 28, 2008
Registry last updated
Jan 25, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.